Shares of YieldMax MRNA Option Income Strategy ETF (NYSEARCA:MRNY – Get Free Report) traded down 0.1% on Tuesday . The company traded as low as $15.18 and last traded at $15.41. Approximately 59,222 shares changed hands during mid-day trading, a decline of 71% from the average session volume of 204,400 shares. The stock had previously closed at $15.42.
YieldMax MRNA Option Income Strategy ETF Price Performance
The stock’s 50-day moving average price is $16.86 and its two-hundred day moving average price is $17.64.
About YieldMax MRNA Option Income Strategy ETF
The YieldMax MRNA Option Income Strategy ETF (MRNY) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to provide current income and capped gains on the Moderna stock (MRNA) through a synthetic covered call strategy, collateralized by cash and US Treasurys. The actively managed fund uses both standardized exchange-traded and FLEX options. MRNY was launched on Oct 23, 2023 and is issued by YieldMax.
Further Reading
- Five stocks we like better than YieldMax MRNA Option Income Strategy ETF
- Asian Market Circuit Breakers Hit Stocks, Not AI Demand
- Riot Platforms Re-Wires the Ledger for a $9B AI Power Play
- Nebius Just Exploded 34% on Blowout Earnings—Is It Time to Buy?
- Joby’s Defense Pivot Accelerates With $500M Resonant Sciences Deal
Receive News & Ratings for YieldMax MRNA Option Income Strategy ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for YieldMax MRNA Option Income Strategy ETF and related companies with MarketBeat.com's FREE daily email newsletter.
